Role of 0.02% polyhexamethylene biguanide and 1% povidone iodine in experimental Aspergillus keratitis

Cornea. 2003 Mar;22(2):138-41. doi: 10.1097/00003226-200303000-00012.

Abstract

Purpose: To determine the efficacy of 0.02% polyhexamethylene biguanide and 1% povidone iodine in experimental keratitis.

Methods: Aspergillus fumigatus keratitis was induced by corneal intrastromal injection of spores in 24 healthy rabbits that were randomly divided into four groups of six rabbits each. Drugs used were 5% natamycin (standard antifungal), 0.02% polyhexamethylene biguanide (PHMB) (test drug), 1% povidone iodine (test drug), and 0.5% hydroxypropylmethyl cellulose (HPMC) (control).

Results: The average healing times of the ulcer were 21.5 +/- 3.08 days with 5% natamycin, 27.8 +/- 2.28 days with 0.02% PHMB, 36.4 +/- 2.57 days with 1% povidone iodine, and 38.2 +/- 4.74 days with 0.5% HPMC. While no corneal perforations occurred with natamycin treatment, one perforation was noted with PHMB, three perforations were noted with povidone iodine, and five perforations were noted with controls.

Conclusion: Polyhexamethylene biguanide (0.02%) is a moderately effective drug for experimental Aspergillus keratitis, but 1% povidone iodine is not effective.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Anti-Infective Agents, Local / therapeutic use*
  • Aspergillosis / drug therapy*
  • Aspergillosis / etiology
  • Aspergillus fumigatus / physiology
  • Biguanides / therapeutic use*
  • Corneal Stroma / microbiology
  • Disinfectants / therapeutic use*
  • Drug Evaluation
  • Eye Infections, Fungal / drug therapy*
  • Eye Infections, Fungal / etiology
  • Keratitis / drug therapy*
  • Keratitis / microbiology
  • Natamycin / therapeutic use
  • Ophthalmic Solutions
  • Povidone-Iodine / therapeutic use*
  • Prospective Studies
  • Rabbits
  • Random Allocation

Substances

  • Anti-Infective Agents, Local
  • Biguanides
  • Disinfectants
  • Ophthalmic Solutions
  • polihexanide
  • Povidone-Iodine
  • Natamycin